NASDAQ · Financial Statements

PharmaCyte Biotech, Inc. (PMCB) Financial Statements

$0.40 NASDAQ: PMCB Market Cap $4.34M

PharmaCyte Biotech, Inc. most recently reported annual revenue of $0, a net loss of $19.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20222023202420252026
Revenue$0$0$0$0$0
Operating Profit$-4.0M$-6.0M$-9.0M$-4.0M$-7.0M
Net Profit$-4.0M$-4.0M$0$31.0M$-19.0M
EPS$-0.27$-0.22$-1.80$3.19$-2.77
Op Margin—————

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$91.0M$73.0M$60.0M$55.0M$47.0M
Total Liabilities$1.0M$1.0M$20.0M$3.0M$12.0M
Cash$85.0M$68.0M$50.0M$15.0M$19.0M
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$-4.0M$-4.0M$-2.0M$-3.0M$-5.0M
Investing Cash Flow$0$0$-5.0M$-7.0M$2.0M
Financing Cash Flow$0$-14.0M$-44.0M$-25.0M$0
Net Cash Flow$83.0M$-17.0M$-18.0M$-35.0M$3.0M
Free Cash Flow$-4.0M$-4.0M$-2.0M$-3.0M$-5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA2.46
FCF Yield-91.72%
Quick Ratio40.30
Interest Coverage—
Return 1Y-36.20%
Return 3Y-75.07%
Return 5Y-94.62%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
PMCB Overview PMCB Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.